
Arthronica is a digital health tech start-up that originated from the bioengineering department of Imperial College London in 2018. The company focuses on supporting patients and healthcare providers in monitoring and treating arthritic conditions through its innovative software. With backing from notable investors like Research England and the Johnson and Johnson Innovation Centre, Arthronica aims to deliver remote care for chronic arthritis globally. The company was acquired by Procedure Health Limited in March 2022, enhancing its capabilities in the healthcare technology space.

Arthronica is a digital health tech start-up that originated from the bioengineering department of Imperial College London in 2018. The company focuses on supporting patients and healthcare providers in monitoring and treating arthritic conditions through its innovative software. With backing from notable investors like Research England and the Johnson and Johnson Innovation Centre, Arthronica aims to deliver remote care for chronic arthritis globally. The company was acquired by Procedure Health Limited in March 2022, enhancing its capabilities in the healthcare technology space.
Founded: 2018 (spin-out from Imperial College London bioengineering)
Product: AI-powered software for monitoring and managing arthritic conditions
Exit: Acquired by Procedure Health Limited in March 2022
Funding / Support: Support from Research England, Entrepreneur First, Johnson & Johnson Innovation Centre
Chronic arthritis monitoring and remote management
2018
Biotechnology
1219044 USD
Listed total funding amount with a last funding date of 2020-07-06 in company snapshot data.
“Research England; Entrepreneur First; Johnson & Johnson Innovation Centre; Crista Galli Ventures; Entrepreneurs First; RebelBio; SOSV”